Treatment of venous thromboembolism: unfractionated heparin or low molecular weight heparins?
Agnelli
G
G
Istituto di Medicina Interna e Medicina Vascolare, Università di Perugia, Italy.
D006493:Heparin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006495:Heparin, Low-Molecular-Weight / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D015201:Meta-Analysis as Topic; D010314:Partial Thromboplastin Time; D011183:Postoperative Complications / Q000188:drug therapy / Q000517:prevention & control; D011446:Prospective Studies; D011655:Pulmonary Embolism / Q000188:drug therapy* / Q000517:prevention & control; D016032:Randomized Controlled Trials as Topic; D013924:Thrombophlebitis / Q000188:drug therapy* / Q000517:prevention & control
D006495:Heparin, Low-Molecular-Weight; D006493:Heparin